Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 48

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

363

HTML

3931

Figures (1-2)

246

Tables (1-3)

193

Sum=4733

Dec 28, 2009 (publication date) through Nov 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 28, 2009; 15(48): 6068-6074
Published online Dec 28, 2009. doi: 10.3748/wjg.15.6068

Table 1 Sociodemographic and clinical characteristics of IBS patients (n = 15) (mean ± SD)

¹According to the Rome II criteria; BMI: Body mass index.

Citation: Kajander K, Myllyluoma E, Kyrönpalo S, Rasmussen M, Sipponen P, Mattila I, Seppänen-Laakso T, Vapaatalo H, Orešič M, Korpela R. Elevated pro-inflammatory and lipotoxic mucosal lipids characterise irritable bowel syndrome. World J Gastroenterol 2009; 15(48): 6068-6074
URL: https://www.wjgnet.com/1007-9327/full/v15/i48/6068.htm
DOI: https://dx.doi.org/10.3748/wjg.15.6068